Multichem® hsTn for Abbott Architect & Alinity instruments.

Third Party QC assayed for the New High Sensitivity Troponin I assay.
Independent quality control of Troponin assays at the new low concentrations is critical to ensure a proper assessment is made before releasing patient test results.

Resources:

Brochure
Multichem hsTn third-party quality control vial

Product Description

Multichem hsTn Control is intended for use as a third party, single level, liquid stable quality control material to monitor the precision of laboratory testing procedures for high sensitive Troponin Assays.

The intended patient population is Cardiac patients, where a requirement has been identified for testing conditions associated with elevated levels of Troponin I and Troponin T.

Multichem hsTn Control is designed as a single level, liquid stable frozen product. The product will typically be run as a low level/high sensitive control, in conjunction with one other level of the Multichem IA /IA Plus series of serum controls for the same analytes, after reagent calibration and at a frequency dictated by laboratory QC procedures and reagent / instrument manufacturer instructions. This product design is based on the existing Multichem IA Plus L1 control, but incorporating the required features of a single low level Troponin Control, to supplement the IA Plus Control to monitor the precision of Troponin assay methods, at the low end of the linear dynamic range .The product should be treated the same as patient specimens and run in accordance with the instructions accompanying the instrument, kit or reagent being used. The control is to be stored at -20°C to –80°C and thawed as per IFU prior to use. The product is to be stored at 2 to 8°C between use.

Show

Benefits

Satisfies regulatory guidelines for use of independent controls

Enhanced stability with low concentrations for Troponin

Improved user confidence in assay performance at the medical decision assay range

Long shelf life extends lot availability

Features

Frozen, Liquid stable, single level control

10 days open vial stability once thawed and stored at 2 to 8 degrees

36 months shelf life once stored at -20 to -80°C degrees

Third party independent quality control

Assayed for Abbott Architect systems

Human based materials used as part of manufacturing process

Mimics performance of commutable patient samples

Analyte List

Troponin I

Ordering

Name

Description

Kit

Part Code

Multichem hsTn

Assayed Single Level

12 x 3mL

04W26-10

Name

Multichem hsTn

Description

Assayed Single Level

Kit

12 x 3mL

Part Code

04W26-10

Contact your local Abbott office to place an order or contact us to learn more

Instructions For Use (IFU)

Multichem IA Plus Instructions for Use

Instructions For Use (IFU)

Log in to our Technical Library to access Multichem hsTn Instructions for Use (IFUs), Data Sheets and XML files.

Technical Library

Find a product by analyte, instrument, partcode or name

Why Technopath

Technopath was the first company in the world to develop truly consolidated third party quality controls for hospital laboratories.

Through the benefits of test consolidated QC, Technopath’s Multichem® customers have increased their laboratory efficiencies and reduced the cost of their quality control program.

Discover More

Our Clients

The main driver for change was a mandate to consolidate and improve workflow efficiencies. Reduced physical cost, coupled with a reduction in staff time, proved significant.

Blackrock Clinic Dublin - Eoin O’Rourke, Head of Pathology, Blackrock Clinic Ltd., Blackrock, Co. Dublin, Ireland

In 2017, Technopath signed a global agreement with Beckman Coulter Diagnostics.

"Technopath’s highly efficient QC solution will help Beckman Coulter customers address the strong and growing demand for multi-constituent quality control products, and meets the requirements of lab accreditation."

John Blackwood - Senior Vice President of Products and Services at Beckman Coulter.

Sign up to our newsletter for the latest updates

Be one of the first to receive news from Technopath Clinical Diagnostics.